Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amarin - 32 Year Stock Price History | AMRN

Historical daily share price chart and data for Amarin since 1993 adjusted for splits and dividends. The latest closing stock price for Amarin as of May 12, 2025 is 10.42.
  • The all-time high Amarin stock closing price was 27500.00 on July 09, 1993.
  • The Amarin 52-week high stock price is 19.10, which is 83.3% above the current share price.
  • The Amarin 52-week low stock price is 7.08, which is 32.1% below the current share price.
  • The average Amarin stock price for the last 52 weeks is 11.85.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Amarin Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 10.3237 10.4720 12.7040 8.0020 10.4200 7.42%
2024 15.5530 17.7840 27.0000 8.8720 9.7000 -44.25%
2023 24.4838 23.8000 43.8000 13.2000 17.4000 -28.10%
2022 39.8223 70.2000 74.6000 21.4000 24.2000 -64.09%
2021 103.0901 100.6000 176.0000 64.8000 67.4000 -31.08%
2020 170.3802 430.6000 430.6000 72.8000 97.8000 -77.19%
2019 364.1571 260.2000 482.4000 252.2000 428.8000 57.53%
2018 144.3048 84.8000 459.6000 49.0000 272.2000 239.40%
2017 66.3661 61.8000 85.8000 57.4000 80.2000 30.19%
2016 46.8516 36.2000 69.4000 25.4000 61.6000 62.96%
2015 40.1429 22.6000 58.0000 20.0000 37.8000 92.92%
2014 30.3917 39.2000 48.0000 16.6460 19.5940 -50.27%
2013 118.2469 162.0000 183.2000 28.0000 39.4000 -75.65%
2012 221.6366 141.0000 309.2000 127.0000 161.8000 8.01%
2011 214.0792 166.6000 390.0000 120.6000 149.8000 -8.67%
2010 53.0791 27.6000 169.8000 19.6000 164.0200 473.54%
2009 23.8716 13.6000 39.0020 10.4000 28.5980 101.39%
2008 38.1171 50.0000 71.7980 12.0000 14.2000 -72.69%
2007 200.1849 436.0000 756.0000 45.0000 52.0000 -88.60%
2006 522.9477 270.0000 748.0000 254.0000 456.0000 90.00%
2005 358.4254 524.0000 680.8000 212.0000 240.0000 -55.72%
2004 277.9263 308.0000 798.0000 106.0000 542.0000 75.97%
2003 580.3368 788.0000 962.0000 278.0000 308.0000 -61.40%
2002 1685.8640 3420.0000 4200.0000 552.0000 798.0000 -77.04%
2001 2692.2460 1100.0000 5594.0000 1000.0000 3475.0000 215.91%
2000 1204.0249 900.0000 1556.2500 750.0000 1100.0000 15.79%
1999 1428.2570 887.5000 2275.0000 825.0000 950.0000 33.33%
1998 2096.1660 6125.0000 6125.0000 200.0000 712.5000 -88.60%
1997 10031.1192 11625.0000 13250.0000 5875.0000 6250.0000 -46.24%
1996 17057.8657 18000.0000 22500.0000 11000.0000 11625.0000 -35.42%
1995 14767.8167 13500.0000 20000.0000 10000.0000 18000.0000 38.46%
1994 15496.5475 17500.0000 21000.0000 9625.0000 13000.0000 -25.71%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.216B $0.229B
Amarin Corporation plc is a commercial-stage pharmaceutical company focused on developing therapies, especially based on omega-3 fatty acid for treating cardiovascular diseases. The company's sole marketed drug, Vascepa (icosapent ethyl) is approved in the United States as an adjunct to diet for treating severe hypertriglyceridemia or elevated triglyceride levels. The FDA approved Vascepa to reduce cardiovascular risk in patients with persistent elevated triglycerides on statin therapy for LDL-C. The drug received approval for both indications in Europe under the tradename of Vazkepa. It has initiated various promotional activities and direct-to-consumer programs as well as expanded its salesforce to support promotion of Vascepa's expanded label. A generic version of Vascepa has been launched for elevated TG levels.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $209.551B 15.64
Amgen (AMGN) United States $142.955B 12.81
Gilead Sciences (GILD) United States $120.549B 12.52
Vertex Pharmaceuticals (VRTX) United States $109.136B 0.00
Bristol Myers Squibb (BMY) United States $94.530B 6.33
GSK (GSK) United Kingdom $75.556B 8.98
CSL (CSLLY) Australia $74.278B 0.00
Regeneron Pharmaceuticals (REGN) United States $56.982B 13.83
Argenex SE (ARGX) Netherlands $33.561B 91.61
Alnylam Pharmaceuticals (ALNY) United States $32.747B 0.00
BeiGene (ONC) Cayman Islands $22.978B 0.00
BioNTech SE (BNTX) Germany $22.301B 0.00
Royalty Pharma (RPRX) United States $19.109B 7.87
Biogen (BIIB) United States $17.315B 7.47
Genmab (GNMSF) Denmark $12.761B 13.05
Genmab (GMAB) Denmark $12.414B 13.93
Illumina (ILMN) United States $11.990B 22.75
Insmed (INSM) United States $11.854B 0.00
Incyte (INCY) United States $11.417B 86.74
BioMarin Pharmaceutical (BMRN) United States $11.288B 18.34
Swedish Orphan Biovitrum (BIOVF) Sweden $10.858B 27.73
Exelixis (EXEL) United States $9.968B 20.67
Exact Sciences (EXAS) United States $9.739B 0.00
Moderna (MRNA) United States $9.378B 0.00
QIAGEN (QGEN) Netherlands $9.305B 18.10
Ascendis Pharma (ASND) Denmark $9.222B 0.00
Halozyme Therapeutics (HALO) United States $8.117B 15.53
Bio-Techne Corp (TECH) United States $7.829B 29.20
Roivant Sciences (ROIV) United Kingdom $7.592B 0.00
Revolution Medicines (RVMD) United States $7.529B 0.00
Repligen (RGEN) United States $6.924B 77.51
Bio-Rad Laboratories (BIO.B) United States $6.566B 22.20
Blueprint Medicines (BPMC) United States $6.275B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.026B 5.81
Legend Biotech (LEGN) United States $5.836B 0.00
Telix Pharmaceuticals (TLX) Australia $5.805B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $5.381B 0.00
TG Therapeutics (TGTX) United States $5.341B 140.17
Axsome Therapeutics (AXSM) United States $5.306B 0.00
Guardant Health (GH) United States $5.169B 0.00
Nuvalent (NUVL) United States $5.001B 0.00
Alkermes (ALKS) Ireland $4.968B 13.33
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $4.763B 0.00
ADMA Biologics Inc (ADMA) United States $4.748B 35.68
Zealand Pharma (ZLDPF) Denmark $4.573B 0.00
Vaxcyte (PCVX) United States $4.020B 0.00
Krystal Biotech (KRYS) United States $3.820B 29.44
Cytokinetics (CYTK) United States $3.785B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.651B 0.00
Sarepta Therapeutics (SRPT) United States $3.565B 0.00
PTC Therapeutics (PTCT) United States $3.506B 6.10
SpringWorks Therapeutics (SWTX) United States $3.469B 0.00
Avidity Biosciences (RNA) United States $3.359B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.319B 0.00
Zai Lab (ZLAB) China $3.226B 0.00
Akero Therapeutics (AKRO) United States $3.175B 0.00
Arcellx (ACLX) United States $3.171B 0.00
Viking Therapeutics (VKTX) United States $3.094B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.076B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.919B 25.65
Alvotech (ALVO) Luxembourg $2.918B 16.69
Scholar Rock Holding (SRRK) United States $2.909B 0.00
Merus (MRUS) Netherlands $2.831B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.682B 0.00
Protagonist Therapeutics (PTGX) United States $2.663B 57.29
Metsera (MTSR) United States $2.508B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.477B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.463B 0.00
Immunovant (IMVT) United States $2.381B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.193B 0.00
Apellis Pharmaceuticals (APLS) United States $2.174B 0.00
Ascentage Pharma Group - (AAPG) China $2.117B 0.00
Vericel (VCEL) United States $2.101B 1391.00
Denali Therapeutics (DNLI) United States $2.088B 0.00
Biohaven (BHVN) United States $2.066B 0.00
Ligand Pharmaceuticals (LGND) United States $2.014B 0.00
Kymera Therapeutics (KYMR) United States $1.958B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.955B 13.00
Bavarian Nordic (BVNRY) Denmark $1.952B 10.31
Belite Bio (BLTE) United States $1.945B 0.00
Certara (CERT) United States $1.944B 36.30
NovoCure (NVCR) Jersey $1.938B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.899B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.881B 0.00
Twist Bioscience (TWST) United States $1.847B 0.00
Amicus Therapeutics (FOLD) United States $1.841B 199.33
ImmunityBio (IBRX) United States $1.827B 0.00
CG Oncology (CGON) United States $1.810B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.789B 0.00
Travere Therapeutics (TVTX) United States $1.778B 0.00
Beam Therapeutics (BEAM) United States $1.751B 0.00
Apogee Therapeutics (APGE) United States $1.674B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.613B 0.00
Agios Pharmaceuticals (AGIO) United States $1.582B 0.00
Edgewise Therapeutics (EWTX) United States $1.534B 0.00
Disc Medicine (IRON) United States $1.529B 0.00
IDEAYA Biosciences (IDYA) United States $1.526B 0.00
Janux Therapeutics (JANX) United States $1.513B 0.00
Structure Therapeutics (GPCR) United States $1.466B 0.00
ANI Pharmaceuticals (ANIP) United States $1.444B 14.80
Immunocore Holdings (IMCR) United Kingdom $1.422B 0.00
Mesoblast (MESO) Australia $1.402B 0.00
MannKind (MNKD) United States $1.386B 28.50
Vera Therapeutics (VERA) United States $1.384B 0.00
Adaptive Biotechnologies (ADPT) United States $1.372B 0.00
Liquidia Technologies (LQDA) United States $1.304B 0.00
GRAIL (GRAL) United States $1.242B 0.00
Celldex Therapeutics (CLDX) United States $1.217B 0.00
Pacira BioSciences (PCRX) United States $1.163B 11.07
Dynavax Technologies (DVAX) United States $1.130B 67.21
89BIO (ETNB) United States $1.124B 0.00
BGM Group (BGM) China $1.072B 0.00
MiMedx (MDXG) United States $1.041B 25.18
NeoGenomics (NEO) United States $1.036B 0.00
WAVE Life Sciences (WVE) Singapore $1.015B 0.00
Viridian Therapeutics (VRDN) United States $1.011B 0.00
Novavax (NVAX) United States $0.968B 2.25
Mineralys Therapeutics (MLYS) United States $0.950B 0.00
Anbio Biotechnology (NNNN) Germany $0.925B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.921B 0.00
Gyre Therapeutics (GYRE) United States $0.893B 238.25
Pharvaris (PHVS) Netherlands $0.888B 0.00
Arcus Biosciences (RCUS) United States $0.877B 0.00
Spyre Therapeutics (SYRE) United States $0.850B 0.00
Intellia Therapeutics (NTLA) United States $0.841B 0.00
Oculis Holding AG (OCS) Switzerland $0.811B 0.00
CorMedix Inc (CRMD) United States $0.791B 53.00
Zymeworks (ZYME) United States $0.787B 0.00
Praxis Precision Medicines (PRAX) United States $0.781B 0.00
CureVac (CVAC) Germany $0.778B 4.23
Geron (GERN) United States $0.752B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.746B 0.00
LENZ Therapeutics (LENZ) United States $0.741B 0.00
Nurix Therapeutics (NRIX) United States $0.724B 0.00
Nuvation Bio (NUVB) United States $0.708B 0.00
Bicara Therapeutics (BCAX) United States $0.707B 0.00
Niagen Bioscience (NAGE) United States $0.705B 99.44
Anavex Life Sciences (AVXL) United States $0.704B 0.00
Vir Biotechnology (VIR) United States $0.703B 0.00
UniQure (QURE) Netherlands $0.701B 0.00
ArriVent BioPharma (AVBP) United States $0.686B 0.00
Pharming Group (PHAR) Netherlands $0.682B 0.00
Trevi Therapeutics (TRVI) United States $0.659B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.654B 0.00
Immunome (IMNM) United States $0.649B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Dianthus Therapeutics (DNTH) United States $0.629B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.626B 0.00
Arbutus Biopharma (ABUS) United States $0.618B 0.00
Pharming Group (PHGUF) Netherlands $0.613B 0.00
AbCellera Biologics (ABCL) Canada $0.606B 0.00
Replimune (REPL) United States $0.594B 0.00
Iovance Biotherapeutics (IOVA) United States $0.584B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.578B 0.00
AnaptysBio (ANAB) United States $0.576B 0.00
Fortrea Holdings (FTRE) United States $0.557B 18.09
Keros Therapeutics (KROS) United States $0.554B 0.00
Cogent Biosciences (COGT) United States $0.548B 0.00
Sionna Therapeutics (SION) United States $0.544B 0.00
GH Research (GHRS) Ireland $0.540B 0.00
Tyra Biosciences (TYRA) United States $0.536B 0.00
Opthea (OPT) Australia $0.525B 0.00
Immatics (IMTX) Germany $0.515B 30.29
Stoke Therapeutics (STOK) United States $0.511B 0.00
Kura Oncology (KURA) United States $0.499B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.486B 0.00
Castle Biosciences (CSTL) United States $0.485B 32.91
Arvinas (ARVN) United States $0.482B 0.00
Urogen Pharma (URGN) United States $0.479B 0.00
Upstream Bio (UPB) United States $0.474B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.464B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.450B 0.00
Eton Pharmaceuticals (ETON) United States $0.450B 0.00
Cullinan Therapeutics (CGEM) United States $0.445B 0.00
MeiraGTx Holdings (MGTX) United States $0.433B 0.00
Abivax SA (ABVX) France $0.426B 0.00
Maze Therapeutics (MAZE) United States $0.421B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.416B 0.00
Sage Therapeutics (SAGE) United States $0.411B 0.00
Sana Biotechnology (SANA) United States $0.410B 0.00
PureTech Health (PRTC) United States $0.403B 0.00
Prothena (PRTA) Ireland $0.400B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.400B 0.00
Northwest Biotherapeutics (NWBO) United States $0.396B 0.00
Kamada (KMDA) Israel $0.395B 26.46
Erasca (ERAS) United States $0.394B 0.00
Precigen (PGEN) United States $0.393B 0.00
Celcuity (CELC) United States $0.384B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.383B 0.00
Zenas BioPharma (ZBIO) United States $0.379B 0.00
REGENXBIO (RGNX) United States $0.377B 0.00
Rapport Therapeutics (RAPP) United States $0.374B 0.00
Alpha Teknova (TKNO) United States $0.372B 0.00
MBX Biosciences (MBX) United States $0.371B 0.00
Cytek Biosciences (CTKB) United States $0.370B 0.00
Verastem (VSTM) United States $0.369B 0.00
Tectonic Therapeutic (TECX) United States $0.369B 0.00
Oric Pharmaceuticals (ORIC) United States $0.361B 0.00
Myriad Genetics (MYGN) United States $0.359B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.351B 0.00
Absci (ABSI) United States $0.351B 0.00
Checkpoint Therapeutics (CKPT) United States $0.349B 0.00
Benitec Biopharma (BNTC) United States $0.320B 0.00
Entrada Therapeutics (TRDA) United States $0.318B 10.35
Olema Pharmaceuticals (OLMA) United States $0.314B 0.00
Emergent Biosolutions (EBS) United States $0.307B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.302B 0.00
Septerna (SEPN) United States $0.298B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.298B 0.00
ATyr Pharma (ATYR) United States $0.292B 0.00
Fulcrum Therapeutics (FULC) United States $0.290B 0.00
XOMA Royalty (XOMA) United States $0.289B 0.00
Prima BioMed (IMMP) Australia $0.270B 0.00
DBV Technologies S.A (DBVT) France $0.269B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Terns Pharmaceuticals (TERN) United States $0.266B 0.00
Aura Biosciences (AURA) United States $0.263B 0.00
Lifecore Biomedical (LFCR) United States $0.258B 0.00
Abeona Therapeutics (ABEO) United States $0.257B 0.00
Cartesian Therapeutics (RNAC) United States $0.257B 0.00
ITeos Therapeutics (ITOS) United States $0.255B 0.00
Allogene Therapeutics (ALLO) United States $0.254B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.253B 0.00
BioStem Technologies (BSEM) $0.252B 10.07
Gossamer Bio (GOSS) United States $0.252B 0.00
Compass Therapeutics (CMPX) United States $0.252B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.252B 51.12
Palvella Therapeutics (PVLA) United States $0.251B 0.00
MaxCyte (MXCT) United States $0.250B 0.00
Monopar Therapeutics (MNPR) United States $0.241B 0.00
Astria Therapeutics (ATXS) United States $0.239B 0.00
ACELYRIN, INC (SLRN) United States $0.238B 0.00
Alumis (ALMS) United States $0.238B 0.00
Candel Therapeutics (CADL) United States $0.237B 0.00
Foghorn Therapeutics (FHTX) United States $0.234B 0.00
Cidara Therapeutics (CDTX) United States $0.234B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.233B 0.00
Atea Pharmaceuticals (AVIR) United States $0.233B 0.00
Third Harmonic Bio (THRD) United States $0.232B 0.00
Bright Minds Biosciences (DRUG) United States $0.229B 0.00
Aardvark Therapeutics (AARD) United States $0.226B 0.00
Rezolute (RZLT) United States $0.224B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.219B 0.00
GENFIT S.A (GNFT) France $0.215B 0.00
Solid Biosciences (SLDB) United States $0.214B 0.00
Adocia (ADOCY) France $0.213B 0.00
Nuvectis Pharma (NVCT) United States $0.212B 0.00
Neurogene (NGNE) United States $0.210B 0.00
Innate Pharma S.A (IPHA) France $0.204B 0.00
Codexis (CDXS) United States $0.204B 0.00
Actuate Therapeutics (ACTU) United States $0.202B 0.00
Semper Paratus Acquisition (TVGN) United States $0.200B 0.00
Kodiak Sciences (KOD) United States $0.199B 0.00
Design Therapeutics (DSGN) United States $0.199B 0.00
Ocugen (OCGN) United States $0.196B 0.00
Inventiva S.A (IVA) France $0.190B 0.00
CARGO Therapeutics (CRGX) United States $0.185B 0.00
Humacyte (HUMA) United States $0.185B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.183B 0.00
Cardiff Oncology (CRDF) United States $0.177B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.176B 0.00
Annexon (ANNX) United States $0.176B 0.00
Voyager Therapeutics (VYGR) United States $0.175B 0.00
TuHURA Biosciences (HURA) United States $0.174B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.173B 0.00
Prime Medicine (PRME) United States $0.171B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.169B 0.00
AC Immune (ACIU) Switzerland $0.169B 0.00
Anika Therapeutics (ANIK) United States $0.167B 0.00
Molecular Partners AG (MOLN) Switzerland $0.166B 0.00
Adherex Technologies (FENC) United States $0.164B 0.00
Inhibrx Biosciences (INBX) United States $0.162B 0.00
Sangamo Therapeutics (SGMO) United States $0.160B 0.00
INmune Bio (INMB) United States $0.160B 0.00
DiaMedica Therapeutics (DMAC) United States $0.157B 0.00
EnGene Holdings (ENGN) Canada $0.151B 0.00
Galena Biopharma (SLS) United States $0.148B 0.00
BioAge Labs (BIOA) United States $0.145B 0.00
Puma Biotechnology (PBYI) United States $0.144B 3.78
Nkarta (NKTX) United States $0.137B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.136B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.126B 0.00
Greenwich LifeSciences (GLSI) United States $0.125B 0.00
Tango Therapeutics (TNGX) United States $0.123B 0.00
ScPharmaceuticals (SCPH) United States $0.123B 0.00
Editas Medicine (EDIT) United States $0.121B 0.00
Theratechnologies (THTX) Canada $0.120B 0.00
Fate Therapeutics (FATE) United States $0.119B 0.00
Alpha Cognition (ACOG) Canada $0.119B 0.00
Alector (ALEC) United States $0.117B 0.00
Vigil Neuroscience (VIGL) United States $0.113B 0.00
Compugen (CGEN) Israel $0.112B 0.00
Coherus BioSciences (CHRS) United States $0.112B 0.00
Genelux (GNLX) United States $0.112B 0.00
Seer (SEER) United States $0.110B 0.00
EXoZymes (EXOZ) United States $0.109B 0.00
InflaRx (IFRX) Germany $0.108B 0.00
Neumora Therapeutics (NMRA) United States $0.107B 0.00
BioHarvest Sciences (BHST) Canada $0.106B 0.00
C4 Therapeutics (CCCC) United States $0.104B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.102B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.102B 0.00
Coya Therapeutics (COYA) United States $0.101B 0.00
Contineum Therapeutics (CTNM) United States $0.100B 0.00
Sagimet Biosciences (SGMT) United States $0.100B 0.00
Rapt Therapeutics (RAPT) United States $0.100B 0.00
Entera Bio (ENTX) Israel $0.098B 0.00
Immunic (IMUX) United States $0.097B 0.00
HilleVax (HLVX) United States $0.095B 0.00
Black Diamond Therapeutics (BDTX) United States $0.093B 0.00
Kyverna Therapeutics (KYTX) United States $0.091B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.089B 0.00
Nautilus Biotechnology (NAUT) United States $0.088B 0.00
Ventyx Biosciences (VTYX) United States $0.088B 0.00
Cellectis S.A (CLLS) France $0.088B 0.00
Elicio Therapeutics (ELTX) United States $0.088B 0.00
Instil Bio (TIL) United States $0.087B 0.00
Pliant Therapeutics (PLRX) United States $0.087B 0.00
Senti Biosciences (SNTI) United States $0.085B 0.00
Elutia (ELUT) United States $0.085B 0.00
XBiotech (XBIT) United States $0.084B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.084B 0.00
Zura Bio (ZURA) United States $0.083B 0.00
Climb Bio (CLYM) United States $0.080B 0.00
Genenta Science S.p.A (GNTA) Italy $0.079B 0.00
Invivyd (IVVD) United States $0.078B 0.00
Adagene (ADAG) China $0.075B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.075B 0.00
CytomX Therapeutics (CTMX) United States $0.075B 2.44
Inozyme Pharma (INZY) United States $0.074B 0.00
CervoMed (CRVO) United States $0.074B 0.00
Sutro Biopharma (STRO) United States $0.074B 0.00
Exicure (XCUR) United States $0.072B 0.00
MediciNova (MNOV) United States $0.072B 0.00
Caribou Biosciences (CRBU) United States $0.072B 0.00
TScan Therapeutics (TCRX) United States $0.072B 0.00
I-Mab (IMAB) United States $0.072B 0.00
Adlai Nortye (ANL) Cayman Islands $0.068B 0.00
Jasper Therapeutics (JSPR) United States $0.068B 0.00
BeyondSpring (BYSI) United States $0.068B 0.00
IGM Biosciences (IGMS) United States $0.068B 0.00
Clearside Biomedical (CLSD) United States $0.066B 0.00
VTv Therapeutics (VTVT) United States $0.066B 0.00
Inovio Pharmaceuticals (INO) United States $0.066B 0.00
IO Biotech (IOBT) Denmark $0.066B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.066B 0.00
VistaGen Therapeutics (VTGN) United States $0.065B 0.00
Medicus Pharma (MDCX) United States $0.062B 0.00
Agenus (AGEN) United States $0.062B 0.00
Seres Therapeutics (MCRB) United States $0.062B 0.00
Biomea Fusion (BMEA) United States $0.061B 0.00
Citius Oncology (CTOR) United States $0.061B 0.00
ZIVO Bioscience (ZIVO) United States $0.061B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Cabaletta Bio (CABA) United States $0.060B 0.00
Alto Neuroscience (ANRO) United States $0.060B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.059B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.059B 0.00
Adverum Biotechnologies (ADVM) United States $0.059B 0.00
Repare Therapeutics (RPTX) Canada $0.058B 0.00
Immix Biopharma (IMMX) United States $0.058B 0.00
Applied Therapeutics (APLT) United States $0.057B 0.00
Skye Bioscience (SKYE) United States $0.056B 0.00
Akoya Biosciences (AKYA) United States $0.055B 0.00
PDS Biotechnology (PDSB) United States $0.055B 0.00
Ikena Oncology (IKNA) United States $0.055B 0.00
Precision BioSciences (DTIL) United States $0.054B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.053B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.052B 0.00
Artiva Biotherapeutics (ARTV) United States $0.051B 0.00
Adicet Bio (ACET) United States $0.050B 0.00
Renovaro (RENB) United States $0.050B 0.00
Fortress Biotech (FBIO) United States $0.050B 0.00
PepGen (PEPG) United States $0.049B 0.00
OKYO Pharma (OKYO) $0.049B 0.00
Oncobiologics (OTLK) United States $0.049B 0.00
Cue Biopharma (CUE) United States $0.048B 0.00
Shattuck Labs (STTK) United States $0.045B 0.00
Quince Therapeutics (QNCX) United States $0.045B 0.00
Oncolytics Biotech (ONCY) Canada $0.045B 0.00
Connect Biopharma Holdings (CNTB) United States $0.045B 0.00
Pluri (PLUR) Israel $0.045B 0.00
Kronos Bio (KRON) United States $0.044B 0.00
Atara Biotherapeutics (ATRA) United States $0.043B 0.00
Opus Genetics (IRD) United States $0.043B 0.00
CAMP4 Therapeutics (CAMP) United States $0.043B 0.00
Lantern Pharma (LTRN) United States $0.043B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.043B 0.00
TELA Bio (TELA) United States $0.043B 0.00
Alterity Therapeutics - (ATHE) Australia $0.043B 0.00
Forte Biosciences (FBRX) United States $0.042B 0.00
Whitehawk Therapeutics (WHWK) United States $0.042B 0.00
Rani Therapeutics Holdings (RANI) United States $0.042B 0.00
Immuneering (IMRX) United States $0.041B 0.00
Celularity (CELU) United States $0.040B 0.00
Mersana Therapeutics (MRSN) United States $0.040B 0.00
Tvardi Therapeutics (TVRD) United States $0.039B 0.00
RenovoRx (RNXT) United States $0.039B 0.00
Rein Therapeutics (RNTX) United States $0.039B 0.00
Estrella Immunopharma (ESLA) United States $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.037B 0.00
Tenaya Therapeutics (TNYA) United States $0.036B 0.00
AN2 Therapeutics (ANTX) United States $0.036B 0.00
Werewolf Therapeutics (HOWL) United States $0.036B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.035B 0.00
Spero Therapeutics (SPRO) United States $0.035B 0.00
Bluebird Bio (BLUE) United States $0.034B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.034B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.033B 0.00
Dyadic (DYAI) United States $0.032B 0.00
Boundless Bio (BOLD) United States $0.032B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.032B 0.00
FibroBiologics (FBLG) United States $0.032B 0.00
Radiopharm Theranostics - (RADX) Australia $0.031B 0.00
Kezar Life Sciences (KZR) United States $0.031B 0.00
Allakos (ALLK) United States $0.030B 0.00
Femasys (FEMY) United States $0.029B 0.00
Cadrenal Therapeutics (CVKD) United States $0.028B 0.00
CalciMedica (CALC) United States $0.028B 0.00
MiNK Therapeutics (INKT) United States $0.028B 0.00
Scilex Holding (SCLX) United States $0.028B 0.00
Grace Therapeutics (GRCE) Canada $0.028B 0.00
Aligos Therapeutics (ALGS) United States $0.027B 0.00
OnKure Therapeutics (OKUR) United States $0.026B 0.00
Dare Bioscience (DARE) United States $0.026B 0.00
BioAtla (BCAB) United States $0.025B 0.00
Quantum Biopharma (QNTM) Canada $0.025B 0.00
Generation Bio (GBIO) United States $0.024B 0.00
Clene (CLNN) United States $0.024B 0.00
Tenax Therapeutics (TENX) United States $0.023B 0.00
ALX Oncology Holdings (ALXO) United States $0.023B 0.00
KALA BIO (KALA) United States $0.022B 0.00
Annovis Bio (ANVS) United States $0.022B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.021B 0.00
Ovid Therapeutics (OVID) United States $0.021B 0.00
Advanced Biomed (ADVB) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.021B 0.00
Passage Bio (PASG) United States $0.020B 0.00
Elevation Oncology (ELEV) United States $0.020B 0.00
ABVC BioPharma (ABVC) United States $0.020B 0.00
Longeveron (LGVN) United States $0.020B 0.00
Curis (CRIS) United States $0.020B 0.00
X4 Pharmaceuticals (XFOR) United States $0.020B 0.00
Lexaria Bioscience (LEXX) Canada $0.019B 0.00
Q32 Bio (QTTB) United States $0.019B 0.00
Vor Biopharma (VOR) $0.019B 0.00
Cognition Therapeutics (CGTX) United States $0.019B 0.00
Chemomab Therapeutics (CMMB) Israel $0.018B 0.00
Lisata Therapeutics (LSTA) United States $0.018B 0.00
Allarity Therapeutics (ALLR) United States $0.018B 0.00
Kalaris Therapeutics (KLRS) United States $0.018B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.017B 0.00
Cingulate (CING) United States $0.017B 0.00
Beyond Air (XAIR) United States $0.017B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.016B 0.00
UNITY Biotechnology (UBX) United States $0.016B 0.00
HOOKIPA Pharma (HOOK) United States $0.016B 0.00
Moleculin Biotech (MBRX) United States $0.015B 0.00
BioCardia (BCDA) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
IN8bio (INAB) United States $0.014B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.014B 0.00
GeoVax Labs (GOVX) United States $0.014B 0.00
Equillium (EQ) United States $0.014B 0.00
Leap Therapeutics (LPTX) United States $0.014B 0.00
Bolt Biotherapeutics (BOLT) United States $0.014B 0.00
Biorestorative Therapies (BRTX) United States $0.014B 0.00
Synlogic (SYBX) United States $0.013B 0.00
Gelteq (GELS) Australia $0.013B 0.00
IBio (IBIO) United States $0.013B 0.00
Hoth Therapeutics (HOTH) United States $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
Rallybio (RLYB) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
Imunon (IMNN) United States $0.012B 0.00
BRIACELL THERAP (BCTX) Canada $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Affimed (AFMD) Germany $0.011B 0.00
LakeShore Biopharma (LSB) China $0.011B 0.00
Cyclerion Therapeutics (CYCN) United States $0.011B 0.00
Abpro Holdings (ABP) United States $0.010B 0.00
Athira Pharma (ATHA) United States $0.010B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.010B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.009B 0.00
Sensei Biotherapeutics (SNSE) United States $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Portage Biotech (PRTG) $0.009B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.009B 0.00
BioXcel Therapeutics (BTAI) United States $0.008B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Aytu BioPharma (AYTU) United States $0.008B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.008B 0.00
Jade Biosciences (JBIO) United States $0.007B 0.00
HCW Biologics (HCWB) United States $0.007B 0.00
GENPREX (GNPX) United States $0.007B 0.00
Biofrontera (BFRI) United States $0.007B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.006B 0.00
MetaVia (MTVA) United States $0.006B 0.00
Apollomics (APLM) United States $0.006B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.006B 0.00
Evogene (EVGN) Israel $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
Mainz Biomed (MYNZ) Germany $0.006B 0.00
180 Life Sciences (ATNF) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
BioAffinity Technologies (BIAF) United States $0.004B 0.00
Novogen (KZIA) Australia $0.004B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Synaptogenix (SNPX) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Eyenovia (EYEN) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Pasithea Therapeutics (KTTA) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Evaxion Biotech (EVAX) Denmark $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Polyrizon (PLRZ) Israel $0.002B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.001B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
Capstone Therapeutics (CAPS) United States $0.000B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00